Orchard Therapeutics Competitors and Similar CompaniesClear all
Orchard Therapeutics's competitors and similar companies include Oxford BioTherapeutics, Stealth BioTherapeutics, Verve Therapeutics and Dyno Therapeutics.
 Orchard Therapeutics Orchard Therapeutics is a biotechnology company, develops and commercializes transformative ex-vivo autologous hematopoietic stem cell gene therapy to restore normal gene function in primary immune deficiencies, metabolic diseases, and hematological disorders. |  Oxford BioTherapeutics Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs. |  Stealth BioTherapeutics Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction. |  Verve Therapeutics Verve Therapeutics is a biotechnology company focused on discovering and developing therapies for heart disease. |  Dyno Therapeutics Dyno Therapeutics is a biotechnology company that provides AI-powered gene therapies. | |
Founding Date | Founding Date 2015 | Founding Date 2004 | Founding Date 2007 | Founding Date 2018 | Founding Date 2018 |
Type | Type Public | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations London, GB HQ Boston, US Boston, US Foster City, US Menlo Park, US | Locations Milton, GB HQ San Jose, US | Locations Newton, US HQ Needham, US | Locations Cambridge, US HQ | Locations Watertown, US HQ |
Employees | Employees 166 | Employees 482% decrease | Employees 592% decrease | Employees 70 | Employees 1074% decrease |
Valuation ($) | Valuation ($) 380.1 m | Valuation ($) N/A | Valuation ($) 18.4 m | Valuation ($) 405.4 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $22.7m (FY, 2022) | Revenue (est.) £2.1m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($150.7m) (FY, 2022) | Net income (£6.5m) (FY, 2018) | Net income ($52.5m) (FY, 2021) | Net income ($200.1m) (FY, 2023) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 10m (about 9 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 100m (over 3 years ago) |
Total funding raised | Total funding raised $ 310.7m | Total funding raised $ 21.6m | Total funding raised $ 100m | Total funding raised $ 152.5m | Total funding raised $ 109m |
For sources of this data, please see the company profile
View Company Profiles
Oxford BioTherapeutics
HQ
Milton, GB
Employees
48↓ 2% decrease
Oxford BioTherapeutics develops medicines for cancer and companion diagnostics for selected antibody programs.
View companyStealth BioTherapeutics
HQ
Newton, US
Employees
59↓ 2% decrease
Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction.
View companyVerve Therapeutics
HQ
Cambridge, US
Employees
70
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies for heart disease.
View companyDyno Therapeutics
HQ
Watertown, US
Employees
107↓ 4% decrease
Dyno Therapeutics is a biotechnology company that provides AI-powered gene therapies.
View company